Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant
Clinical trial NCT03755310 · UNKNOWN
Trial details
- NCT number
- NCT03755310
- Sponsor
- Diego García-Borreguero, MD, PhD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2020-03-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.